0001179110-21-006329.txt : 20210603
0001179110-21-006329.hdr.sgml : 20210603
20210603161805
ACCESSION NUMBER: 0001179110-21-006329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carter Percy H.
CENTRAL INDEX KEY: 0001863024
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 21992715
MAIL ADDRESS:
STREET 1: C/O BLUEPRINT MEDICINES CORPORATION
STREET 2: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2021-06-01
0
0001597264
Blueprint Medicines Corp
BPMC
0001863024
Carter Percy H.
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Scientific Officer
Common Stock
2021-06-01
4
A
0
21843
0
A
21843
D
Stock Option (Right to Buy)
89.16
2021-06-01
4
A
0
39200
0
A
2031-06-01
Common Stock
39200
39200
D
The reported transaction involved the Reporting Person's receipt of a grant of 21,843 restricted stock units under the Issuer's 2020 Inducement Plan.
This option vests with respect to 25% of the shares underlying the option on June 1, 2022 and as to an additional 1/48th of the shares underlying the option each month thereafter.
/s/ Ariel Hurley, Attorney-in-Fact
2021-06-03